We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a case-control study to evaluate your digital health product.
Employment Tribunal decision.
How to use A/B testing to evaluate your digital health product.
Compare different evaluation approaches and choose an appropriate method.
An overview of national surveillance programmes that explain the transmission of COVID-19 and other priority infections and how they are affecting the wider population.
How to use a think aloud study to evaluate your digital health product.
This helpdesk review has drawn primarily on evidence from systematic reviews and synthesis studies
Outcome(s) by the Central Arbitration Committee on an application from Prospect.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
How to use feedback from marketplace reviews to evaluate your digital health product.
Results of a survey undertaken with health systems researchers worldwide to assess equity-oriented current practice in LMICs
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).